These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Factors affecting choice of hemostatic agent for the hemophilia patient with an inhibitor antibody.
    Author: Monahan PE, Aledort LM, Hemophilia Inhibitor Study Group.
    Journal: Am J Hematol; 2004 Dec; 77(4):346-50. PubMed ID: 15558804.
    Abstract:
    Achieving adequate hemostasis in patients with hemophilia and high-titer inhibitor antibodies remains a challenge despite the development of plasma-derived and recombinant therapies to bypass the inhibitory effect. A group of hemophilia treaters met to examine the factors that influence physician choices among the very costly and cumbersome available therapies. Specific knowledge deficits in need of prospective research were identified with respect to the rational treatment of inhibitor patients.
    [Abstract] [Full Text] [Related] [New Search]